Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 272, Issue 6 16-6, 1997, Pages

  Blau, Hanna ^b   Riklis, Shoshana ^b   Van Iwaarden, J Freer ^b   McCormack, Francis X ^b   Kalina, Moshe ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b NONE

Author keywords

Inducible nitric oxide synthase; Interferon ; Lipopolysaccharide; Type II cells

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LIPID A; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT GAMMA INTERFERON; SURFACTANT ASSOCIATED PROTEIN; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; IN VITRO STUDY; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030806365     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1997.272.6.l1198     Document Type: Article

References (31)

1. Blau, H., S. Riklis, V. Kravtsov, and M. Kalina. Secretion of cytokines by rat alveolar epithelial cells: possible regulatory role for SP-A. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L148-L155, 1994.
2. Crapo, J. D., and J. R. Wright. SP-A deficiency - a cause or consequence of inflammation in bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 151: 595-596, 1995.
3. Dawson, V. L., T. M. Dawson, E. D. London, D. S. Bredt, and S. H. Snyder. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA 88: 6386-6371, 1991.
4. Denis, M. Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium. Killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukoc. Biol. 48: 380-387, 1991.
5. Dijkstra, C. D., E. A. Dopp, P. Joling, and G. Kraal. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulation in the rat recognized by the monoclonal antibodies ED1, ED2, and ED3. Immunology 54: 589-601, 1985.
6. Dobbs, L., G. R. Gonzalez, and M. C. Williams. An improved method for isolating type II cells in high yield and purity. Am. Rev. Respir. Dis. 134: 141-145, 1986.
7. Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149: 538-551, 1994.
8. Ialenti, A., A. Ianar, S. Moncada, and M. Dir Rosa. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211: 177-182, 1992.
9. Jorgens, P. G., F. J. Van Overveld, H. Bult, P. A. Vermeire, and A. G. Herman. L-Arginine-dependent production of nitrogen oxides by rat pulmonary macrophages. Eur. J. Pharmacol. 200: 205-209, 1991.
10. Kalina, M., S. Riklis, and H. J. Blau. Pulmonary epithelial cell proliferation in primary culture of alveolar type II cells. Exp. Lung Res. 19: 153-175, 1993.
11. Klebanoff, S. J. Oxygen metabolites from phagocytes. In: Inflammation - Basic Principles and Clinical Correlates, edited by J. I. Gallin, I. M. Goldstein, and R. Snyderman. New York: Raven, 1992, p. 541-588.
12. Kremlev, S. G., and D. S. Phelps. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am. J. Physiol. 267 (Lung Cell. Mol. Physiol. 11): L712-L719, 1994.
13. Kuroki, Y., R. J. Mason, and D. R. Voelker. Pulmonary surfactant apoprotein A structure and modulation of surfactant secretion by rat alveolar type II cells. J. Biol. Chem. 263: 3388-3394, 1988.
14. Kuroki, Y., R. J. Mason, and D. R. Voelker. Alveolar type II cells express a high affinity receptor for pulmonary surfactant protein A. Proc. Natl. Acad. Sci. USA 85: 5566-5570, 1988.
15. Lavnikova, M., J. C. Drapier, and D. L. Laskin. A single exogenous stimulus activates resident rat macrophages for nitric oxide production and tumor cytotoxicity. J. Leukoc. Biol. 54: 322-328, 1993.
16. McCormack, F. X., H. Calvert, D. L. Smith, and D. R. Voelker. Surfactant protein A modified genetic deletion of the carbohydrate and collagen-like domains regulates the secretion of surfactant from type II cells (Abstract). FASEB J. 6: A371, 1992.
17. Moncada, S., R. M. J. Palmer, and E. A. Higgs. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43: 109-142, 1991.
18. Nicholas, D. J. D., and A. Nason. Nitrite determination by diazotization and coupling reactions. In: Methods in Enzymology, edited by S. P. Colowick and N. O. Kaplon. New York: Academic, 1957, vol. 3, p. 983-984. 1957.
19. Pendino, J. J., J. D. Laskin, R. L. Shuler, C. J. Punjabi, and D. L. Laskin. Enhanced production of nitric oxide by rat alveolar macrophages following inhalation of a pulmonary irritant is associated with increased expression of nitric oxide synthase. J. Immunol. 151: 7196-7205, 1993.
20. Pisono, U., M. Max, A. Neuendank, S. Weibbach, and S. Pietschmann. Host defence capacities of pulmonary surfactant: evidence for "non-surfactant" functions of the surfactant system. Eur. J. Clin. Invest. 24: 586-599, 1994.
21. Punjabi, C. J., J. D. Laskin, K. J. Pendino, N. L. Goller, S. K. Durham, and D. L. Laskin. Production of nitric oxide by rat type II pneumocytes: increased expression of inducible nitric oxide synthase following inhalation of a pulmonary irritant. Am. J. Respir. Cell Mol. Biol. 11: 165-172, 1994.
22. Raetz, C. R. H., R. J. Ulevitch, S. D. Wright, C. H. Sibley, A. Ding, and C. F. Nathan. Gram-negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB J. 5: 2652-2660, 1991.
23. Tenner, A. J., S. L. Robinson, J. Brochelt, and J. R. Wright. Human pulmonary surfactant protein (SP-A, a protein structurally homologous to C1Q), can enhance FcR-and CR1-mediated phagocytosis. J. Biol. Chem. 264: 13923-13928, 1989.
24. Thorkelsson, T., C. F. Ross, J. A. Whitsett, and R. E. Morris. Lectin activity of the major surfactant protein (SP-A) may participate in, but is not required for binding to rat type II cells. J. Histochem. Cytochem. 40: 643-649, 1992.
25. Van Iwaarden, J. F., F. Teding van Berkhout, J. A. Whitsett, R. S. Oosting, and L. M. G. van Golde. A novel procedure for the rapid isolation of surfactant protein A with retention of its alveolar-macrophage-stimulating properties. Biochem. J. 309: 551-555, 1995.
26. Van Iwaarden, J. F., J. A. G. Van Stripp, H. Visser, H. P. Haagsman, J. Verhoef, and L. M. G. Van Golde. Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A. J. Biol. Chem. 267: 35039-25043, 1992.
27. Van Iwaarden, F., B. Welmers, J. Verhoef, H. P. Haagsman, and L. M. G. Van Golde. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 2: 91-98, 1990.
28. Voss, T., K. P. S. Chafer, P. F. Nielson, A. Schafer, C. Maier, E. Hannappel, J. Maasden, B. Landis, K. Kiemm, and M. Przyblyski. Primary structure differences of human surfactant associated proteins isolated from normal and proteinosis lungs. Biochim. Biophys. Acta 113: 261-267, 1992.
29. Warner, R. L., R. Paine III, P. J. Christensen, M. A. Marietta, M. K. Richards, S. E. Wilcoxen, and P. A. Ward. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. Am. J. Respir. Cell Mol. Biol. 12: 649-661, 1995.
30. Weaver, T. E., and J. A. Whitsett. Structure and function of pulmonary surfactant proteins. Semin. Perinatol. 12: 213-220, 1988.
31. Wright, J. R., R. E. Wager, S. Hawgood, L. Dobbs, and J. A. Clements. Surfactant apoprotein M2-26000-36000 enhances uptake of liposomes by type II cells. J. Biol. Chem. 262: 2888-2894, 1987.